Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
CUROGEN logo — Cure for Humanity's Health

CUROGEN

Cure for Humanity's Health

Founded 2019 Korea South Korea South 5 employees Biopharma, Biotechnology

General Information

Company Name CUROGEN
Founded Year 2019
Location Korea South Korea South +2
Employees 5
Industries Biopharma, Biotechnology
Social

Get notified when CUROGEN moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CUROGEN

Curogen is a biopharmaceutical startup founded in 2019 with a mission to address unmet medical needs related to autoimmune diseases such as Psoriasis, Inflammatory Bowel Disease, Ankylosing Spondylitis, and Rheumatoid Arthritis, as well as cancer, including Hepatocellular Carcinoma and B-cell Lymphoma. The company's slogan, "Cure for Humanity's Health," encapsulates their commitment to finding solutions for these challenging conditions. Curogen's focus on research and development stands out, as they aim to develop therapeutics in various forms including small molecule compounds, soluble fusion proteins, and recombinant virus-based gene therapies. Their dedication to addressing critical health issues positions them at the forefront of the biopharma and biotechnology industries. While details about their headquarters, last investment, and investors are currently unavailable, Curogen's innovative approach and focus on impactful therapeutics make it a promising prospect for potential venture capital investment.

Taxonomy: Autoimmune diseases, Medical research and development, Therapeutics, Small molecule compounds, Fusion proteins, Recombinant virus-based gene therapies, Psoriasis treatment, Inflammatory Bowel Disease treatment, Ankylosing Spondylitis treatment, Rheumatoid Arthritis treatment, Hepatocellular Carcinoma treatment, B-cell Lymphoma treatment, Disease targets, Immunology

No funding data available for CUROGEN yet.

Get notified when CUROGEN raises funding

CUROGEN Alternatives & Competitors

CUROGEN vs
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. United States

Developing a potentially disease-modifying, new drug treatment for Alzheimer’s and other neurodegene...

Series Unknown
12 employees
Biotechnology
CUROGEN vs
HAYA Therapeutics
HAYA Therapeutics Switzerland

Programmable Therapeutics for Causal Biology - Science Guides Us. The Genome Powers Us. Patients Gr...

Undisclosed
68 employees
Biopharma, Biotechnology
CUROGEN vs
Attralus
Attralus United States

Attralus is a biopharmaceutical company creating transformative medicines for patients with systemic...

Unknown
21 employees
Biopharma, Biotechnology

FAQ About CUROGEN

Cure for Humanity's Health
CUROGEN was founded in 2019.
CUROGEN is headquartered in Korea South.
CUROGEN operates in the following industries: Biopharma, Biotechnology.
CUROGEN has approximately 5 employees.
Top alternatives and competitors to CUROGEN include T3D Therapeutics, Inc., HAYA Therapeutics, Attralus, Edgewise Therapeutics, CHASE THERAPEUTICS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CUROGEN and T3D Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CUROGEN and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy